Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo.

Hepatology (Baltimore, Md.) - 1 Feb 2012

Meuleman Philip, Catanese Maria Teresa, Verhoye Lieven, Desombere Isabelle, Farhoudi Ali, Jones Christopher T, Sheahan Timothy, Grzyb Katarzyna, Cortese Riccardo, Rice Charles M, Leroux-Roels Geert, Nicosia Alfredo

Abstract excerpt

UNLABELLED: Endstage liver disease caused by chronic hepatitis C virus (HCV) infection is the leading indication for liver transplantation in the Western world. However, immediate reinfection of the grafted donor liver by circulating virus is inevitable and liver disease progresses much faster than the original disease. Standard antiviral therapy is not well tolerated and usually ineffective in liver transplant...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to CD36 Antigens

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Line, Tumor

Share to Chimera

Share to Hepatitis C

Share to Liver Transplantation

Share to Mice, SCID

Share to Secondary Prevention

Source

Open in PubMed Open full text

Identifiers

PMID: 21953761
DOI: 10.1002/hep.24692
PMCID: PMC3262867

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo.PMID 21953761Read ↗

Novel human SR-BI antibodies prevent infection and dissemination of HCV in vitro and in humanized mice.Semantic proximity Read ↗

Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agentsSemantic proximity Read ↗

Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81Semantic proximity Read ↗

Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice.Semantic proximity Read ↗

A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo.Semantic proximity Read ↗

Scavenger receptor class B type I is more conducive for genotype 1b hepatitis C virus internalization than low-density lipoprotein receptor.Semantic proximity Read ↗

Scavenger receptor class B type I and the hypervariable region-1 of hepatitis C virus in cell entry and neutralisationSemantic proximity Read ↗

Coexistence of hepatitis B virus quasispecies enhances viral replication and the ability to induce host antibody and cellular immune responses.Semantic proximity Read ↗

Persistent hepatitis B virus and HIV coinfections in dually humanized mice engrafted with human liver and immune systemSemantic proximity Read ↗

Different Requirements for Scavenger Receptor Class B Type I in Hepatitis C Virus Cell-Free versus Cell-to-Cell TransmissionSemantic proximity Read ↗

The potent broadly neutralizing antibody VIR-3434 controls Hepatitis B and D Virus infection and reduces HBsAg in humanized miceSemantic proximity Read ↗

Broadly neutralizing antibodies abrogate established hepatitis C virus infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.